Research: 
Tirzepatide is a dual agonist medication that activates GIP and GLP-1 receptors. It activates two hormone receptors that are crucial for regulating blood sugar and appetite. It is approved for treating type 2 diabetes, and research has demonstrated significant weight loss benefits by increasing insulin release, decreasing glucagon, slowing gastric emptying, and promoting feelings of fullness.